Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: April 19, 2023
As
an
essential
micronutrient,
manganese
plays
important
role
in
the
physiological
process
and
immune
process.
In
recent
decades,
cGAS-STING
pathway,
which
can
congenitally
recognize
exogenous
endogenous
DNA
for
activation,
has
been
widely
reported
to
play
critical
roles
innate
immunity
against
some
diseases,
such
as
infections
tumor.
Manganese
ion
(Mn2+)
recently
proved
specifically
bind
with
cGAS
activate
pathway
a
potential
agonist,
however,
is
significantly
restricted
by
low
stability
of
Mn2+
further
medical
application.
one
most
stable
forms
manganese,
dioxide
(MnO2)
nanomaterials
have
show
multiple
promising
functions,
drug
delivery,
anti-tumor
anti-infection
activities.
More
importantly,
MnO2
are
also
found
be
candidate
agonist
transforming
into
Mn2+,
indicates
their
regulations
different
diseased
conditions.
this
review,
we
introduced
methods
preparation
well
biological
Moreover,
emphatically
discussed
detailed
mechanisms
activation
converting
Mn2+.
And
application
disease
treatment
regulating
might
benefit
future
development
novel
targeted
treatments
based
on
nanoplatforms.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: May 23, 2023
The
immunologically
"cold"
microenvironment
of
triple
negative
breast
cancer
results
in
resistance
to
current
immunotherapy.
Here,
we
reveal
the
immunoadjuvant
property
gas
therapy
with
cyclic
GMP-AMP
synthase-stimulator
interferon
genes
(cGAS-STING)
pathway
activation
augment
aggregation-induced
emission
(AIE)-active
luminogen
(AIEgen)-based
photoimmunotherapy.
A
virus-mimicking
hollow
mesoporous
tetrasulfide-doped
organosilica
is
developed
for
co-encapsulation
AIEgen
and
manganese
carbonyl
fabricate
nanoadjuvant.
As
tetra-sulfide
bonds
are
responsive
intratumoral
glutathione,
nanoadjuvant
achieves
tumor-specific
drug
release,
promotes
photodynamic
therapy,
produces
hydrogen
sulfide
(H2S).
Upon
near-infrared
laser
irradiation,
AIEgen-mediated
phototherapy
triggers
burst
carbon
monoxide
(CO)/Mn2+.
Both
H2S
CO
can
destroy
mitochondrial
integrity
induce
leakage
DNA
into
cytoplasm,
serving
as
immunoadjuvants
activate
cGAS-STING
pathway.
Meanwhile,
Mn2+
sensitize
cGAS
STING-mediated
type
I
production.
Consequently,
potentiates
photoimmunotherapy
poorly
immunogenic
tumors
female
mice.
Journal of the American Chemical Society,
Journal Year:
2023,
Volume and Issue:
145(10), P. 5803 - 5815
Published: Feb. 27, 2023
The
antioxidant
system,
signed
with
reduced
glutathione
(GSH)
overexpression,
is
the
key
weapon
for
tumor
to
resist
attack
by
reactive
oxygen
species
(ROS).
Counteracting
ROS
depletion
GSH
an
effective
strategy
guarantee
antitumor
efficacy
of
nanocatalytic
therapy.
However,
simply
reducing
concentration
does
not
sufficiently
improve
response
therapy
intervention.
Herein,
a
well-dispersed
MnOOH
nanocatalyst
developed
catalyze
autoxidation
and
peroxidase-like
reaction
concurrently
respectively
promote
H2O2
decomposition
produce
abundant
such
as
hydroxyl
radical
(·OH),
thereby
generating
highly
superadditive
catalytic
therapeutic
efficacy.
Such
that
transforms
endogenous
"antioxidant"
into
"oxidant"
may
open
new
avenue
development
medicine.
Moreover,
released
Mn2+
can
activate
sensitize
cGAS-STING
pathway
damaged
intratumoral
DNA
double-strands
induced
produced
further
macrophage
maturation
M1-polarization,
which
will
boost
innate
immunotherapeutic
Resultantly,
simple
medicine
capable
simultaneously
catalyzing
generation,
mediating
immune
activation,
holds
great
potential
in
treatment
malignant
tumors.
Materials Advances,
Journal Year:
2023,
Volume and Issue:
4(21), P. 5050 - 5093
Published: Jan. 1, 2023
The
use
of
zinc-based
MOFs
in
a
variety
cancer
treatments
was
comprehensively
reviewed.
advantages
and
disadvantages,
as
well
the
application
prospects
future,
are
also
discussed.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(7)
Published: Oct. 5, 2023
Promoting
innate
immunity
through
pyroptosis
induction
or
the
cyclic
GMP-AMP
synthase-stimulator
of
interferon
gene
(cGAS-STING)
pathway
activation
has
emerged
as
a
potent
approach
to
counteract
immunosuppressive
tumor
microenvironment
and
elicit
systemic
antitumor
immunity.
However,
current
inducers
STING
agonists
often
suffer
from
limitations
including
instability,
unpredictable
side
effects,
inadequate
intracellular
expression
gasdermin
STING.
Here,
tumor-specific
nanotheranostic
platform
that
combines
photodynamic
therapy
(PDT)
with
epigenetic
simultaneously
activate
cGAS-STING
in
light-controlled
manner
is
constructed.
This
involves
development
oxidation-sensitive
nanoparticles
(NP1)
loaded
photosensitizer
TBE,
along
decitabine
nanomicelles
(NP2).
NP2
enables
restoration
E
(GSDME)
expression,
while
NP1-mediated
PDT
facilitates
release
DNA
fragments
damaged
mitochondria
potentiate
pathway,
promotes
caspase-3
cleave
upregulated
GSDME
into
pore-forming
GSDME-N
terminal.
Subsequently,
released
inflammatory
cytokines
facilitate
maturation
antigen-presentation
cells,
triggering
T
cell-mediated
Overall,
this
study
presents
an
elaborate
strategy
for
simultaneous
photoactivation
enabling
targeted
photoimmunotherapy
immunotolerant
tumors.
innovative
holds
significant
promise
overcoming
associated
existing
therapeutic
modalities
represents
valuable
avenue
future
clinical
applications.
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 571 - 608
Published: Jan. 1, 2024
Abstract:
With
the
development
of
nanotechnology,
nanoparticles
(NPs)
have
shown
broad
prospects
as
drug
delivery
vehicles.
However,
they
exhibit
certain
limitations,
including
low
biocompatibility,
poor
physiological
stability,
rapid
clearance
from
body,
and
nonspecific
targeting,
which
hampered
their
clinical
application.
Therefore,
novel
systems
with
improved
biocompatibility
high
target
specificity
remains
a
major
challenge.
In
recent
years,
biofilm
mediated
biomimetic
nano-drug
system
(BNDDS)
has
become
research
hotspot
focus
in
field
life
sciences.
This
new
platform
uses
bio-nanotechnology
to
encapsulate
synthetic
NPswithin
membrane,
organically
integrating
immunogenicity,
toxicity,
tumor
good
adjustability
versatility
nanocarrier,
shows
promising
applications
precision
therapy.
this
review,
we
systematically
summarize
progress
BNDDS
used
for
optimizing
delivery,
providing
theoretical
reference
designing
safe
efficient
treatment
strategies
improve
outcomes.
Keywords:
nanoparticles,
cell
targeted
therapy
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(23)
Published: Feb. 28, 2024
Abstract
Stimulating
the
cyclic
guanosine
monophophate(GMP)‐adenosine
monophosphate
(AMP)
synthase
(cGAS)‐stimulator
of
interferon
genes
(STING)
pathway
is
a
crucial
strategy
by
which
bacteria
activate
tumor
immune
system.
However,
limited
stimulation
capability
poses
significant
challenges
in
advancing
bacterial
immunotherapy.
Here,
an
adenosine
5′‐triphosphate
(ATP)‐responsive
manganese
(Mn)‐based
material
(
E.
coli
@PDMC‐PEG
(polyethylene
glycol))
engineered
successfully,
exhibits
exceptional
ability
to
synergistically
cGAS‐STING
pathway.
In
microenvironment,
characterized
elevated
ATP
levels,
this
biohybrid
degrades,
resulting
release
divalent
ions
(Mn
2+
)
and
subsequent
exposure.
This
combination
activates
pathway,
as
Mn
enhances
sensitivity
cGAS
extracellular
DNA
(eDNA)
secreted
bacteria.
The
results
vivo
experiments
demonstrate
that
materials
VNP20009@PDMC‐PEG
effectively
inhibit
growth
subcutaneous
melanoma
mice
situ
liver
cancer
rabbits.
Valuable
insights
for
development
bacteria‐based
immunotherapy
are
provided
here.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(21)
Published: Feb. 14, 2024
Activation
of
the
cyclic
GMP-AMP
synthase-stimulator
interferon
genes
(cGAS-STING)
pathway
has
emerged
as
an
efficient
strategy
to
improve
therapeutic
outcomes
immunotherapy.
However,
"constantly
active"
mode
current
STING
agonist
delivery
strategies
typically
leads
off-target
toxicity
and
hyperimmunity.
To
address
this
critical
issue,
herein
a
metal-organic
frameworks-based
nanoagonist
(DZ@A7)
featuring
tumor-specific
near-infrared
(NIR)
light-enhanced
decomposition
is
constructed
for
precisely
localized
activation
photodynamic-metalloimmunotherapy.
The
engineered
enabled
generation
mitochondria-targeted
reactive
oxygen
species
under
NIR
irradiation
specifically
release
mitochondrial
DNA
(mtDNA)
inhibit
repair
nuclear
via
hypoxia-responsive
drugs.
Oxidized
tumor
mtDNA
serves
endogenous
danger-associated
molecular
pattern
that
activates
cGAS-STING
pathway.
Concurrently,
NIR-accelerated
zinc
ions
overloading
in
cancer
cells
further
enhance
cGAS
enzymatic
activity
through
metalloimmune
effects.
By
combining
synergistically
enhanced
triggered
by
irradiation,
facilitated
maturation
dendritic
infiltration
cytotoxic
T
lymphocytes
primary
eradication,
which
also
established
long-term
anti-tumor
immunity
suppress
metastasis.
Therefore,
developed
NIR-triggered,
agonist-free,
tandem-amplified
pathway,
thereby
offering
distinct
paradigm
Exploration,
Journal Year:
2024,
Volume and Issue:
4(6)
Published: March 22, 2024
Abstract
Metals
are
an
emerging
topic
in
cancer
immunotherapy
that
have
shown
great
potential
modulating
immunity
cycle
and
promoting
antitumor
by
activating
the
intrinsic
immunostimulatory
mechanisms
which
been
identified
recent
years.
The
main
challenge
of
metal‐assisted
lies
fact
free
metals
as
ion
forms
easily
cleared
during
circulation,
even
cause
systemic
metal
toxicity
due
to
off‐target
effects.
With
rapid
development
nanomedicine,
metal‐based
smart
nanosystems
(MSNs)
with
unique
controllable
structure
become
one
most
promising
delivery
carriers
solve
issue,
owing
their
various
endogenous/external
stimuli‐responsiveness
release
ions
for
metalloimmunotherapy.
In
this
review,
state‐of‐the‐art
research
progress
metal‐related
is
comprehensively
summarized.
First,
mainstream
MSNs‐assisted
will
be
delineated.
immunological
effects
certain
categorization
MSNs
different
characters
compositions
then
provided,
followed
representative
exemplar
applications
treatment,
synergistic
combination
immunotherapy.
Finally,
we
conclude
review
a
summary
remaining
challenges
associated
provide
authors'
perspective
on
further
advances.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 4, 2025
Nowadays,
emerging
evidence
have
suggested
that
the
ferroptosis
of
macrophages
could
contribute
to
progression
atherosclerosis
(AS).
Meanwhile,
Spermine
(Sp)
serve
as
an
endogenous
small
molecule
exhibiting
a
wide
range
cardiovascular
protective
effects.
Zeolitic
imidazolate
framework-90
(ZIF90)
nanoparticles
were
synthesized
and
utilized
create
novel
delivery
nanosystem
encapsulated
with
Sp
(CD16/32-ZIF90@Sp).
The
efficacy
CD16/32-ZIF90@Sp
in
protecting
against
AS
was
evaluated
ApoE-/-
mice
macrophages,
focus
on
assessing
potential
adverse
effects
vivo.
exhibited
reliable
stable
within
acidic
environments
ATP
sensitivity.
effectively
reduced
cytotoxicity
Sp.
As
is
evidenced
by
vitro
vivo
experiments,
showed
precise
targeting
atherosclerotic
plaques
ox-LDL-activated
macrophages.
Furthermore,
treatment
attenuated
macrophage
plaque
without
causing
significant
side
Mechanistically,
we
found
inhibited
via
improving
mitochondrial
function
upregulating
expression
level
GPX4/xCT.
Our
study
demonstrated
CD16/32-modified
ZIF90
target
plaques,
leading
inhibition
mice.
These
attributed
enhancement
ferroptosis,
limited
Advanced Materials,
Journal Year:
2022,
Volume and Issue:
35(3)
Published: Nov. 3, 2022
Among
the
few
available
mRNA
delivery
vehicles,
lipid
nanoparticles
(LNPs)
are
most
clinically
advanced
but
they
require
cumbersome
four
components
and
suffer
from
inflammation-related
side
effects
that
should
be
minimized
for
safety.
Yet,
a
certain
level
of
proinflammatory
responses
innate
immune
activation
required
to
evoke
T-cell
immunity
cancer
vaccination.
To
address
these
issues
develop
potent
yet
low-inflammatory
vaccine
vectors,
series
alternating
copolymers
"PHTA"
featured
with
ortho-hydroxy
tertiary
amine
(HTA)
repeating
units
is
synthesized,
which
can
play
triple
roles
condensing
mRNA,
enhancing
polymeric
nanoparticle
(PNP)
stability,
prolonging
circulation
time.
Unlike
LNPs
exhibiting
high
levels
inflammation,
PHTA-based
PNPs
show
negligible
inflammatory
in
vivo.
Importantly,
top
candidate
PHTA-C18
enables
successful
vivo
leads
robust
CD8+
T
cell
mediated
antitumor
cellular
immunity.
Such
integrated
PNP
provides
potential
approach
establishing
vaccines
good
safety
profiles.